Ignite Creation Date:
2024-05-05 @ 10:00 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00006265
Status:
COMPLETED
Last Update Posted:
2016-07-14
First Post:
2000-09-11
Brief Title:
Gemtuzumab Ozogamicin and High-Dose Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Sponsor:
Organization:
Alliance for Clinical Trials in Oncology